HCM
VIVS

Highbridge Capital Management’s VivoSim Labs VIVS Stock Holding History

Highbridge Capital Management’s Portfolio VIVS Stock Details VIVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-282
Closed -$255K – 1867
2015
Q2 		$255K Buy
+282
New +$315K ﹤0.01% 1197

Other funds holding VIVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TI
Think Investments San Francisco, California $762M AUM 33.1% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Highbridge Capital Management's VIVS Position: Q3 2015 in Review

Highbridge Capital Management sold out of VivoSim Labs (VIVS) in Q3 2015, closing a stake of 631 shares — an estimated $571K sold.

Highbridge Capital Management first reported a position in VIVS in Q2 2015 and held it in 1 quarter. The position peaked at $571K in Q2 2015. 115 funds tracked by Wall St. Rank hold VIVS as of Q3 2015.

  • Highbridge Capital Management reported no remaining VivoSim Labs position as of Q3 2015 after selling out during the quarter.
  • Highbridge Capital Management sold 631 VivoSim Labs shares in Q3 2015, an estimated $571K.
  • Highbridge Capital Management first reported a position in VivoSim Labs in Q2 2015 and held it in 1 quarter.
  • Highbridge Capital Management's VivoSim Labs position peaked at $571K in Q2 2015.
  • 115 funds tracked by Wall St. Rank held VivoSim Labs as of Q3 2015.

Based on Highbridge Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.